Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/CureVac> ?p ?o }
Showing triples 1 to 59 of
59
with 100 triples per page.
- CureVac abstract "CureVac is a biopharmaceutical company headquartered in Tübingen, Germany, that develops therapies based on messenger RNA (mRNA). The main research primarily focuses on cancer immunotherapies and prophylactic vaccines against infectious diseases. Founded in 2000, CureVac currently has about 240 employees.Since inception, CureVac had received approximately $330 million (€300 million) in equity investments. CureVac has entered into various collaborations with multinational corporations and organizations, including agreements with Boehringer Ingelheim, Sanofi Pasteur, Johnson & Johnson, the Bill & Melinda Gates Foundation and the International AIDS Vaccine Initiative.".
- CureVac industry Biotechnology.
- CureVac location Tübingen.
- CureVac type Privately_held_company.
- CureVac wikiPageExternalLink www.curevac.com.
- CureVac wikiPageID "39161114".
- CureVac wikiPageLength "12491".
- CureVac wikiPageOutDegree "29".
- CureVac wikiPageRevisionID "706383524".
- CureVac wikiPageWikiLink Afatinib.
- CureVac wikiPageWikiLink Bill_&_Melinda_Gates_Foundation.
- CureVac wikiPageWikiLink Biopharmaceutical.
- CureVac wikiPageWikiLink Biotechnology.
- CureVac wikiPageWikiLink Boehringer_Ingelheim.
- CureVac wikiPageWikiLink CV9202.
- CureVac wikiPageWikiLink Cancer_Research_Institute.
- CureVac wikiPageWikiLink Category:Biopharmaceutical_companies.
- CureVac wikiPageWikiLink Category:Cancer_organizations.
- CureVac wikiPageWikiLink Dietmar_Hopp.
- CureVac wikiPageWikiLink Epidermal_growth_factor_receptor.
- CureVac wikiPageWikiLink Germany.
- CureVac wikiPageWikiLink International_AIDS_Vaccine_Initiative.
- CureVac wikiPageWikiLink Johnson_&_Johnson.
- CureVac wikiPageWikiLink Ludwig_Cancer_Research.
- CureVac wikiPageWikiLink Messenger_RNA.
- CureVac wikiPageWikiLink Non-small-cell_lung_carcinoma.
- CureVac wikiPageWikiLink Privately_held_company.
- CureVac wikiPageWikiLink Sanofi_Pasteur.
- CureVac wikiPageWikiLink The_Bill_&_Melinda_Gates_Foundation.
- CureVac wikiPageWikiLink Tübingen.
- CureVac wikiPageWikiLink University_of_Tübingen.
- CureVac wikiPageWikiLinkText "CureVac".
- CureVac wikiPageUsesTemplate Template:Infobox_company.
- CureVac wikiPageUsesTemplate Template:Refimprove.
- CureVac wikiPageUsesTemplate Template:Reflist.
- CureVac subject Category:Biopharmaceutical_companies.
- CureVac subject Category:Cancer_organizations.
- CureVac hypernym Company.
- CureVac type Agent.
- CureVac type Company.
- CureVac type Organisation.
- CureVac type Organization.
- CureVac type Organization.
- CureVac type Organization.
- CureVac type Agent.
- CureVac type SocialPerson.
- CureVac type Thing.
- CureVac type Q43229.
- CureVac comment "CureVac is a biopharmaceutical company headquartered in Tübingen, Germany, that develops therapies based on messenger RNA (mRNA). The main research primarily focuses on cancer immunotherapies and prophylactic vaccines against infectious diseases. Founded in 2000, CureVac currently has about 240 employees.Since inception, CureVac had received approximately $330 million (€300 million) in equity investments.".
- CureVac label "CureVac".
- CureVac sameAs Q1144473.
- CureVac sameAs CureVac.
- CureVac sameAs m.0tkjcpg.
- CureVac sameAs Q1144473.
- CureVac wasDerivedFrom CureVac?oldid=706383524.
- CureVac homepage www.curevac.com.
- CureVac homepage http://www.curevac.com//.
- CureVac isPrimaryTopicOf CureVac.
- CureVac name "CureVac GmbH.".